20 November, 2025
This investment will enable the company to finalize the technical development of its solution and accelerate the industrialization of its production (...)
6 November, 2025
Founded in 2021, Genomines is a deeptech startup that uses biotechnology to reinvent the mining industry.
This funding will enable Genomines to (...)
4 November, 2025
Guylène Kiesel Le Cosquer
Our experts, Guylène Kiesel Le Cosquer, Partner and Board Member, and Ina Schreiber, Partner and Head of the Patent Department, represent Plasseraud (...)
5 November, 2025
On October 22, 2025, the biopharmaceutical group Ipsen announced that it had entered into a definitive agreement to acquire ImCheck Therapeutics, a (...)
5 November, 2025
Plasseraud IP is proud to announce that Cyra Nargolwalla, Bertrand Loisel, Eric Burbaud, and Ina Schreiber have once again been ranked among the best (...)
5 November, 2025
Plasseraud IP is proud to announce that Cyra Nargolwalla, Bertrand Loisel, Eric Burbaud, and Ina Schreiber have once again been ranked among the best (...)
23 September, 2025
The IAM Strategy 300: The World’s Leading IP Strategists identifies professionals who stand out for their strategic vision and ability to maximize (...)
22 July, 2025
Founded in September 2012, SpliceBio is a clinical-stage genetic medicine company pioneering protein splicing to treat diseases caused by large gene (...)
10 July, 2025
Plasseraud IP is delighted to once again be recognized as Tier 1 in the “Patent prosecution (2025)” category and, for the second time, as Tier 3 in (...)
22 May, 2025
Plasseraud IP is pleased to announce that Cyra Nargolwalla, Bertrand Loisel, Eric Burbaud and Ina Schreiber have once again been recognized among the (...)
紹介資料を開く